Translatum Medicus Inc. was founded by Dr Shelley Boyd, an Ophthalmologist specializing in diseases of the retina, and scientist at St Michael’s Hospital.

In addition to her focus on science and medicine, Dr Boyd was formerly Head of the Ocular Angiogenesis Research Program worldwide for Novartis Pharmaceuticals, Switzerland, and helped bring today’s treatment for wet AMD to patients around the globe. She uniquely aligns her knowledge of science, medicine and the pharmaceutical industry, and combines this with her passion for patient care.

Dr. Boyd is Founding Director of the only Canadian “High Risk Dry AMD Clinic” at St Michael’s Hospital, Toronto, and the Ophthalmology Patient Education & Research Centre (Eye-PERC). 4 studies are currently under way.